Timothy D. Smith

Timothy D. Smith

Auto-generated profile, based on publicly available information

Timothy D. Smith

Human Variome Project International Coordinating Office, Melbourne, Australia

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 March 2016 in Human Mutation
Verified
Journal Article
Open access
PDF file
JDJohan T Den Dunnen
Johan T Den Dunnen
RDRaymond Dalgleish
Raymond Dalgleish
DMDonna R Maglott
Donna R Maglott
RHReece Hart
Reece Hart
MGMarc S Greenblatt
Marc S Greenblatt
PTPeter E M Taschner
Peter E M Taschner
The consistent and unambiguous description of sequence variants is essential to report and exchange information on the analysis of a genome. In particular, DNA diagnostics critically depends on accurate and standardized description and sharing of the variants detected. The sequence variant nomenclature system proposed in 2000 by the Human Genome Variation Society has been widely adopted and has developed into an internationally accepted standard. The recommendations are currently commissioned through a Sequence Variant Description Working Group (SVD‐WG) operating under the auspices of three international organizations: the Human Genome Variation Society (HGVS), the Human Variome Project (HVP), and the Human Genome Organization (HUGO). Requests for modifications and extensions go through the SVD‐WG following a standard procedure including a community consultation step. Version numbers are assigned to the nomenclature system to allow users to specify the version used in their variant descriptions. Here, we present the current recommendations, HGVS version 15.11, and briefly summarize the changes that were made since the 2000 publication. Most focus has been on removing inconsistencies and tightening definitions allowing automatic data processing. An extensive version of the recommendations is available online, at http://www.HGVS.org/varnomen.

7 November 2008 in Science
Verified
Journal Article
Closed access
PDF file
RCRichard G. H. Cotton
Richard G. H. Cotton
AAArleen D. Auerbach
Arleen D. Auerbach
MAMyles Axton
Myles Axton
CBCarol Isaacson Barash
Carol Isaacson Barash
Sam BerkovicSam Berkovic
Sam Berkovic
MWMichael Watson
Michael Watson
An ambitious plan to collect, curate, and make accessible information on genetic variations affecting human health is beginning to be realized.

20 January 2009 in Human Mutation
Verified
Journal Article
Open access
PDF file
JKJim Kaput
Jim Kaput
RCRichard G.H. Cotton
Richard G.H. Cotton
LHLauren Hardman
Lauren Hardman
MWMichael Watson
Michael Watson
AAAida I. Al Aqeel
Aida I. Al Aqeel
OMOn Behalf Of Contributors To The Human Variome Project Planning Meeting
On Behalf Of Contributors To The Human Variome Project Planning Meeting
The remarkable progress in characterizing the human genome sequence, exemplified by the Human Genome Project and the HapMap Consortium, has led to the perception that knowledge and the tools (e.g., microarrays) are sufficient for many if not most biomedical research efforts. A large amount of data from diverse studies proves this perception inaccurate at best, and at worst, an impediment for further efforts to characterize the variation in the human genome. Because variation in genotype and environment are the fundamental basis to understand phenotypic variability and heritability at the population level, identifying the range of human genetic variation is crucial to the development of personalized nutrition and medicine. The Human Variome Project (HVP; http://www.humanvariomeproject.org/) was proposed initially to systematically collect mutations that cause human disease and create a cyber infrastructure to link locus specific databases (LSDB). We report here the discussions and recommendations from the 2008 HVP planning meeting held in San Feliu de Guixols, Spain, in May 2008. Hum Mutat 30, 496–510, 2009.

24 September 2007 in Journal of Medical Genetics
Verified
Journal Article
Open access
PDF file
RGR A George
R A George
TST D Smith
T D Smith
SCS Callaghan
S Callaghan
LHL Hardman
L Hardman
CPC Pierides
C Pierides
RCR G H Cotton
R G H Cotton
Databases of mutations causing Mendelian disease play a crucial role in research, diagnostic and genetic health care and can play a role in life and death decisions. These databases are thus heavily used, but only gene or locus specific databases have been previously reviewed for completeness, accuracy, currency and utility. We have performed a review of the various general mutation databases that derive their data from the published literature and locus specific databases. Only two—the Human Gene Mutation Database (HGMD) and Online Mendelian Inheritance in Man (OMIM)—had useful numbers of mutations. Comparison of a number of characteristics of these databases indicated substantial inconsistencies between the two databases that included absent genes and missing mutations. This situation strengthens the case for gene specific curation of mutations and the need for an overall plan for collection, curation, storage and release of mutation data.

19 November 2008 in Human Mutation
Verified
Journal Article
Open access
PDF file
SZSophia Zaimidou
Sophia Zaimidou
SBSjozef van Baal
Sjozef van Baal
TSTimothy D. Smith
Timothy D. Smith
KMKonstantinos Mitropoulos
Konstantinos Mitropoulos
MLMila Ljujic
Mila Ljujic
GPGeorge P. Patrinos
George P. Patrinos
We have developed a relational database of human SERPINA1 gene mutations, leading to α1-antitrypsin (AAT) deficiency, called A1ATVar, which can be accessed over the World Wide Web at www.goldenhelix.org/A1ATVar. Extensive information has been extracted from the literature and converted into a searchable database, including genotype information, clinical phenotype, allelic frequencies for the commonest AAT variant alleles, methods of detection, and references. Mutation summaries are automatically displayed and user-generated queries can be formulated based on fields in the database. A separate module, linked to the FINDbase database for frequencies of inherited disorders allows the user to access allele frequency information for the three most frequent AAT alleles, namely PiM, PiS, and PiZ. The available experimental protocols to detect AAT variant alleles at the protein and DNA levels have been archived in a searchable format. A visualization tool, called VariVis, has been implemented to combine A1ATVar variant information with SERPINA1 sequence and annotation data. A direct data submission tool allows registered users to submit data on novel AAT variant alleles as well as experimental protocols to explore SERPINA1 genetic heterogeneity, via a password-protected interface. Database access is free of charge and there are no registration requirements for querying the data. The A1ATVar database is the only integrated database on the Internet offering summarized information on AAT allelic variants and could be useful not only for clinical diagnosis and research on AAT deficiency and the SERPINA1 gene, but could also serve as an example for an all-in-one solution for locus-specific database (LSDB) development and curation. Hum Mutat 0,1–6, 2008.

8 February 2011 in Human Mutation
Verified
Journal Article
Open access
PDF file
JAJumana AlAama
Jumana AlAama
TSTimothy D. Smith
Timothy D. Smith
ALAlan Lo
Alan Lo
HHHeather Howard
Heather Howard
AKAlexandria A. Kline
Alexandria A. Kline
RCRichard G.H. Cotton
Richard G.H. Cotton
Genetic diseases are a pressing global health problem that requires comprehensive access to basic clinical and genetic data to counter. The creation of regional and international databases that can be easily accessed by clinicians and diagnostic labs will greatly improve our ability to accurately diagnose and treat patients with genetic disorders. The Human Variome Project is currently working in conjunction with human genetics societies to achieve this by establishing systems to collect every mutation reported by a diagnostic laboratory, clinic, or research laboratory in a country and store these within a national repository, or HVP Country Node. Nodes have already been initiated in Australia, Belgium, China, Egypt, Malaysia, and Kuwait. Each is examining how to systematically collect and share genetic, clinical, and biochemical information in a country‐specific manner that is sensitive to local ethical and cultural issues. This article gathers cases of genetic data collection within countries and takes recommendations from the global community to develop a procedure for countries wishing to establish their own collection system as part of the Human Variome Project. We hope this may lead to standard practices to facilitate global collection of data and allow efficient use in clinical practice, research and therapy. Hum Mutat 32:1–6, 2011.